Delivery Order SPE2DB22D1106-SPE2DB24FERE5

Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $18K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,767.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $27,554.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product Nurtec ODT 75 mg tablets, with a completion date of February 6, 2024. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Nurtec ODT 75 mg tablets. The contract, valued at $1,054.76, was awarded by the Defense Logistics Agency (DLA) on July 11, 2022, with a completion date of July 12, 2022. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $14,574.44 for the pharmaceutical product Nurtec ODT 75 mg tablet. The award was issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. military. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
This contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Firm Fixed Price Delivery Order valued at $27,601.87. The award covers the delivery of Nurtec ODT 75 mg tablets to support the DLA's medical supply needs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nurtec ODT 75 mg tablets. The contract has a ceiling value of $12,574.59 and runs through February 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $13,821.73 for the pharmaceutical product Nurtec ODT 75 mg tablets. The award was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has an ultimate completion date of February 9, 2024 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $9,425.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of Nurtec ODT 75 mg tablets, a pharmaceutical product, with a completion date of November 9, 2023. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, holds a...
This federal contract award, valued at $11,899.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nurtec ODT 75 mg tablets. The contract has a completion date of June 12, 2023 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that serves as a critical supplier of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) for the delivery of Nurtec ODT 75 mg tablets. The $21,819.43 firm fixed-price contract has a performance period through May 1, 2024 and does not include any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FERE5
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $17,570.01, is for the delivery of Nurtec ODT 75 mg tablets. It is a firm-fixed-price delivery order contract that runs through May 10, 2024.

Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also a major pharmaceutical distributor. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 5/16/25, 11:47 AM